Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT2 | O75908 | 1/20 | 0.56 |
| ▸ | ACAT1 | P24752 | 1/20 | 0.56 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5900890 | 1.00 | SOAT2 (0.56) | SOAT2ACAT1SOAT1 | |
| SCHEMBL5900949 | 1.00 | SOAT2 (0.56) | SOAT2ACAT1SOAT1 | |
| SCHEMBL6941039 | 0.83 | — | — | |
| SCHEMBL6942238 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL5900881 | 0.80 | — | — | |
| SCHEMBL6939463 | 0.80 | — | — | |
| SCHEMBL7077869 | 0.80 | — | — | |
| SCHEMBL5972843 | 0.79 | — | — | |
| SCHEMBL6940716 | 0.79 | — | — | |
| SCHEMBL6246993 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060135785-A1 | Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof | PIERRE FABRE MEDICAMENT (FR) | 2006-06-22 | — | — | US | claimed |
| US-20060135785-A1 | Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof | PIERRE FABRE MEDICAMENT (FR) | 2006-06-22 | — | — | US | disclosed |
| EP-1558590-A1 | ALPHA-PHENYL ACETANILIDE DERIVATIVES HAVING AN ACAT INHIBITING ACTIVITY AND THE THERAPEUTIC APPLICATION THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2005-08-03 | — | — | EP | disclosed |
| WO-2004035552-A1 | ALPHA-PHENYL ACETANILIDE DERIVATIVES HAVING AN ACAT INHIBITING ACTIVITY AND THE THERAPEUTIC APPLICATION THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2004-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135785-A1 | Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof | ACAT2, ACAT1, LCAT | SOAT2 109/4885ACAT1 2/4885SOAT1 43/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.